Kutlu O, et al. - Researchers investigated the impact of dexpanthenol as a novel choice for female pattern hair loss (FPHL), by employing the Dermatologic Life Quality Index (DLQI) and a modified hair growth questionnaire. Participants were women who were treated with 500 mg intramuscular dexpanthenol (DXP) weekly for FPHL. As far as overall satisfaction with the appearance of the hair was concerned, 57.1% of the participants stated “ I am satisfied”, 28.6% “I am very satisfied” and 14.3% “I am neutral (neither satisfied nor dissatisfied)”. The mean DLQI scores prior to vs following DXP treatment varied statistically. Based on the findings, experts concluded that dexpanthenol affords a safe and novel treatment choice that may increase the quality of life in patients experiencing FPHL.